Synora Evidence home

Services

Statistical design and analysis support for studies that combine trial evidence with real-world data. Engagements can range from a focused design review to ongoing support through a regulatory submission.

Hybrid control trial design

Hybrid control trials augment a randomized control arm with external controls, such as patients from prior trials, registries, or natural history studies. Done well, they can reduce the number of patients randomized to control while protecting the validity of the comparison.

  • Choice and assessment of external control sources
  • Borrowing strategies that adapt to how comparable the external data are
  • Sample size and power calculations for hybrid and single-arm designs
  • Operating characteristics and simulation studies
  • Statistical analysis plans for the primary and sensitivity analyses

RWD and RWE study design

Real-world data can answer questions trials cannot, but only when the study is designed to be fit for purpose.

  • Feasibility and fitness-for-purpose assessment of data sources
  • Target trial emulation and protocol development
  • Handling of missing data and irregular follow-up
  • Generalizing or transporting trial findings to real-world populations

Causal inference

Careful causal reasoning is what turns observational and integrated data into credible evidence.

  • Confounding adjustment with robust and efficient estimators
  • Integrative analysis of randomized and observational data
  • Heterogeneous treatment effects and individualized treatment rules
  • Quantitative sensitivity analysis for unmeasured confounding

Regulatory statistical support

Support for sponsors and foundations preparing to engage with the FDA on designs that use external or real-world data.

  • Statistical sections of briefing packages and meeting requests
  • Protocols and statistical analysis plans
  • Responses to regulatory statistical questions
  • Alignment with current FDA guidance on real-world evidence and externally controlled trials

Planning a trial that uses external or real-world data?

Get in touch early. Design choices made before a protocol is written, and before the first regulatory meeting, shape everything that follows.

Start a conversation